Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2013-05-01 / Anticancer Res. 2013 May;33(5):2047-56Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2013-04-19 / Cancer Immunol. Immunother. 2013 Jun;62(6):1083-91Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLC /von 2013-04-16 / Cancer Immunol. Immunother. 2013 May;62(5):909-18Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2013-03-21 / Cancer Lett. 2013 Aug;336(2):253-9Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study
/in Dendritic Cells, Hypernephroma, International Publications /von 2013-03-04 / Hum Vaccin Immunother 2013 Jun;9(6):1217-27The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-03-01 / Oncoimmunology 2013 Mar;2(3):e23401Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity
/in Dendritic Cells, International Publications /von 2013-02-15 / Cancer Res. 2013 Apr;73(8):2493-504Current status of immunotherapy for the treatment of biliary tract cancer
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2013-02-01 / Hum Vaccin Immunother 2013 May;9(5):1069-72Vaccine strategies for glioblastoma: progress and future directions
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / Immunotherapy 2013 Feb;5(2):155-67
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de